Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 13.71 M | $2.31 B | 2.44% | 13.58% |
| JPMORGAN CHASE & CO | 08/12/2026 | 6.40 M | $1.09 B | 17.58% | 6.34% |
| DODGE & COX | 08/13/2026 | 5.58 M | $941.22 M | 2.26% | 5.53% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 4.97 M | $838.31 M | 5.24% | 4.92% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.55 M | $766.05 M | 0.74% | 4.50% |
| STATE STREET CORP | 08/07/2026 | 4.39 M | $739.13 M | 0.71% | 4.34% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.82 M | $643.47 M | -22.70% | 3.78% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 2.34 M | $393.68 M | -3.43% | 2.31% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.14 M | $359.61 M | 0.10% | 2.12% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 2.08 M | $349.92 M | -32.16% | 2.06% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 1.88 M | $316.85 M | 50.40% | 1.86% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.49 M | $251.86 M | 0.03% | 1.48% |
| MORGAN STANLEY | 08/13/2026 | 1.32 M | $222.23 M | 8.15% | 1.31% |
| RTW INVESTMENTS, LP | 08/14/2026 | 1.27 M | $213.69 M | 19.38% | 1.26% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.26 M | $212.31 M | 1.36% | 1.25% |
| INVESCO LTD. | 08/14/2026 | 1.08 M | $181.57 M | 202.61% | 1.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 974.28 K | $164.20 M | 7.92% | 0.96% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 974.28 K | $164.20 M | 100.00% | 0.96% |
| NORGES BANK | 08/12/2026 | 973.88 K | $164.13 M | 100.00% | 0.96% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 923.13 K | $155.58 M | -3.76% | 0.91% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 732.88 K | $123.53 M | 2.97% | 0.73% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 726.11 K | $122.38 M | 39.56% | 0.72% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 699.13 K | $117.83 M | -0.48% | 0.69% |
| SWEDBANK AB | 07/15/2026 | 651.08 K | $109.73 M | 12.37% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 647.76 K | $109.17 M | 2.12% | 0.64% |
| IEQ CAPITAL, LLC | 08/11/2026 | 640.30 K | $107.91 M | -16.41% | 0.63% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 631.89 K | $106.50 M | 80.97% | 0.63% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 619.35 K | $104.38 M | 6.08% | 0.61% |
| VICTORY CAPITAL MANAGEMENT INC | 08/07/2026 | 618.50 K | $104.24 M | -15.46% | 0.61% |
| MAN GROUP PLC | 08/14/2026 | 601.02 K | $101.29 M | 44.51% | 0.60% |
| ROYAL BANK OF CANADA | 08/14/2026 | 583.48 K | $98.34 M | 75.59% | 0.58% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 580.17 K | $97.78 M | -3.54% | 0.57% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2026 | 567.42 K | $95.63 M | -4.43% | 0.56% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 553.07 K | $93.21 M | -9.52% | 0.55% |
| UBS GROUP AG | 08/13/2026 | 545.94 K | $92.01 M | -55.29% | 0.54% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 08/14/2026 | 539.96 K | $91.00 M | 476.75% | 0.53% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 535.84 K | $90.31 M | -25.99% | 0.53% |
| JUPITER TOPCO LLC | 08/14/2026 | 526.34 K | $88.71 M | 100.00% | 0.52% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 504.23 K | $84.98 M | -11.80% | 0.50% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 502.27 K | $84.66 M | -1.91% | 0.50% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 491.34 K | $82.81 M | -1.01% | 0.49% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2026 | 469.23 K | $79.08 M | 16.03% | 0.46% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 461.27 K | $60.77 M | -11.89% | 0.46% |
| NUVEEN, LLC | 08/11/2026 | 459.30 K | $77.41 M | 3.67% | 0.45% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 441.37 K | $74.37 M | 25.85% | 0.44% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 430.64 K | $72.75 M | -28.54% | 0.43% |
| PACER ADVISORS, INC. | 08/13/2026 | 419.77 K | $70.75 M | 148.05% | 0.42% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 373.55 K | $62.96 M | 32.42% | 0.37% |
| FIERA CAPITAL CORP | 08/07/2026 | 373.19 K | $62.90 M | -42.70% | 0.37% |
| GOTHAM ASSET MANAGEMENT, LLC | 08/14/2026 | 371.57 K | $62.62 M | 3.17% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 1074 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 13.71 M
JPMORGAN CHASE & CO: 6.4 M
DODGE & COX: 5.58 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 4.97 M
VANGUARD CAPITAL MANAGEMENT LLC: 4.55 M
STATE STREET CORP: 4.39 M
100.94% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 153.63 M shares in the last 24 months. This purchase volume represents approximately $19.96 B in transactions.